P. Case et al., ACCESS TO STERILE SYRINGES IN MAINE - PHARMACY PRACTICE AFTER THE 1993 REPEAL OF THE SYRINGE PRESCRIPTION LAW, Journal of acquired immune deficiency syndromes and human retrovirology, 18, 1998, pp. 94-101
In October 1993, the Maine legislature repealed the prescription law r
egulating the sale of syringes. The new law allowed but did not requir
e licensed pharmacists to dispense syringes without a prescription to
anyone 18 years of age or older. From November 1995 to January 1996, w
e conducted a telephone survey of 208 Maine pharmacists to evaluate th
e sale of syringes with and without a prescription and to assess pharm
acists' willingness to sell syringes without a prescription. We found
that 94% of pharmacists were willing, in all cases or at the discretio
n of the pharmacist, to sell syringes without a prescription. However,
when asked specifically about willingness to sell syringes without a
prescription to suspected injection drug users (IDUs) greater than or
equal to 18 years of age, 47% were willing, 40% were not willing, and
13% did not know or declined to answer. Pharmacists reported other req
uirements for the purchase of syringes without a prescription, such as
the requirement for the customer to provide a reasonable justificatio
n for the purchase. In all, there were 31 (15%) pharmacists in the sam
ple willing to sell syringes to without a prescription with no additio
nal requirements for purchase to suspected IDUs as permitted by law. T
here were few negative incidents reported involving IDUs and the sale
of syringes without a prescription since amendment of the law. Althoug
h sales of syringes without a prescription were reported, the numbers
sold fell short of the estimated number of syringes required for IDUs
in Maine to use a new syringe for every injection. Despite the change
in the prescription law intended to increase access to syringes, the d
ata suggest barriers such as drug paraphernalia laws and pharmacy poli
cies may prevent IDUs from purchasing syringes and contribute to ongoi
ng transmission of HIV. Amendment of the drug paraphernalia and syring
e possession laws, clarification of the legitimate medical purpose of
access to sterile syringes for IDUs, and offering pharmacists continui
ng education on the prevention of blood-borne disease appear to be nec
essary steps in the effort to decrease the transmission of HIV among I
DUs in Maine.